Top compounds associated with response to HORMAD1


Feature Type Standardized
Nominal ANOVA
mRNA erastin CTRPv2 pan-cancer AAC -0.086 0.02
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.13 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.02
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.077 0.02
mRNA SRT-1720 CTRPv2 pan-cancer AAC -0.087 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.17 0.02
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.087 0.03
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC -0.087 0.03
Download CSV